droxidopa has been researched along with Amyloid Neuropathy Type 1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Otero-Losada, M; Pérez-Lloret, S; Quarracino, C; Rascol, O | 1 |
1 review(s) available for droxidopa and Amyloid Neuropathy Type 1
| Article | Year |
|---|---|
Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases.
Topics: Amyloid Neuropathies, Familial; Blood Pressure; Droxidopa; Humans; Hypotension, Orthostatic; Japan; Neurodegenerative Diseases; Parkinson Disease; Renal Dialysis; Surveys and Questionnaires | 2019 |